WASHINGTON, Nov. 9 -- Rep. Brad Wenstrup, R-Ohio, a Republican member of the House Ways and Means Committee, issued the following news release: "The Inflation Reduction Act will wipe out nearly a third of the current annual spending on cancer research and development, leading to fewer new cures and discouraging innovation and investment in an industry that relies heavily on private sector funding," writes Ways and Means Member and co-chair of the GOP Doctors Caucus Rep. Brad Wenstrup (R-OH) in   more